Add like
Add dislike
Add to saved papers

Inhibition of Na + /K + - and Ca 2+ -ATPase activities by phosphotetradecavanadate.

Polyoxometalates (POMs) are promising inorganic inhibitors for P-type ATPases. The experimental models used to study the effects of POMs on these ATPases are usually in vitro models using vesicles from several membrane sources. Very recently, some polyoxotungstates, such as the Dawson anion [P2 W18 O62 ]6- , were shown to be potent P-type ATPase inhibitors; being active in vitro as well as in ex-vivo. In the present study we broaden the spectrum of highly active inhibitors of Na+ /K+ -ATPase from basal membrane of epithelial skin to the bi-capped Keggin-type anion phosphotetradecavanadate Cs5.6 H3.4 PV14 O42 (PV14 ) and we confront the data with activity of other commonly encountered polyoxovanadates, decavanadate (V10 ) and monovanadate (V1 ). The X-ray crystal structure of PV14 was solved and contains two trans-bicapped α-Keggin anions Hx PV14 O42 (9-x)- . The anion is built up from the classical Keggin structure [(PO4 )@(V12 O36 )] capped by two [VO] units. PV14 (10 μM) exhibited higher ex-vivo inhibitory effect on Na+ /K+ -ATPase (78%) than was observed at the same concentrations of V10 (66%) or V1 (33%). Moreover, PV14 is also a potent in vitro inhibitor of the Ca2+ -ATPase activity (IC50 5 μM) exhibiting stronger inhibition than the previously reported activities for V10 (15 μM) and V1 (80 μM). Putting it all together, when compared both P-typye ATPases it is suggested that PV14 exibited a high potential to act as an in vivo inhibitor of the Na+ /K+ -ATPase associated with chloride secretion.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app